Holds one active US DMF and 2 valid CEPs for vardenafil, filing since 2012. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds one active US DMF and 2 valid CEPs for vardenafil, filing since 2014. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds one active US DMF for vardenafil, filing since 2016. Its 2025 FDA inspection closed as NAI.
Registered with SFDA (Saudi Arabia) for vardenafil. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and one valid CEP for vardenafil, filing since 2018. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for vardenafil, filing since 2019. Its 2018 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for vardenafil, filing since 2025. Its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for vardenafil. Its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for vardenafil. Its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Vardenafil manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free